Diabetes
Ready-To-Use Insulin for IV Infusion Granted FDA Approval
Ready-To-Use Insulin for IV Infusion Granted FDA Approval
The drug is indicated for use as a short-acting human insulin to improve glycemic control in adults and pediatric patients with diabetes mellitus. It is only intended to use in acute care settings under medical supervision.
 
Read More >>
Monday Pharmaceutical Mystery: July 22
App Offers Retinopathy Screening for Patients with Diabetes
Empagliflozin Earns FDA Fast Track Designation for Chronic Heart Failure
Understanding Chronic Kidney Disease in Patients with Diabetes
Features of a Rapid-Acting Insulin Option for Adult Patients With Diabetes
FDA Approves Liraglutide for Pediatric Patients with Type 2 Diabetes
Topical Insulin May Provide Relief to Patients with Diabetes and Dry Eyes
View more articles >>
Clinical Trials
Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy
Comprehension of Discharge Instructions for Diabetes Therapy and Hospital Readmission
Impact of Diabetes Continuing Education on Primary Health Care Physicians' Knowledge, Attitudes and Practice
Taking Action: a Care for Type 2 Diabetes Intervention for Couples
A Behavioral Intervention to Prevent Impaired Glucose Tolerance Diabetes Mellitus (DIGITAL-I)
Multimedia: Videos
May 3 Pharmacy Week in Review: Health Care Providers Urged to Encourage Parents to Vaccinate Their Children, Study Demonstrates Safety of Oral Immunotherapy for Peanut Allergy
May 3 Pharmacy Week in Review: Health Care Providers Urged to Encourage Parents to Vaccinate Their Children, Study Demonstrates Safety of Oral Immunotherapy for Peanut Allergy
Exciting Therapies and Technologies in T2D
Exciting Therapies and Technologies in T2D
Navigating Patients Through T2D Therapy in the Pharmacy
Navigating Patients Through T2D Therapy in the Pharmacy
Certified Diabetes Educator: A Resource for Patients
Certified Diabetes Educator: A Resource for Patients